Since its establishment in 1990, BMG LABTECH has become a world leader in microplate reading due to continuous development of innovative and unique technologies. BMG LABTECH is one of the world’s leading manufacturers of microplate readers with subsidiaries in Australia, France, Japan, UK, and the USA. The company, with its headquarters and production in Germany, has developed a wide range of dedicated and multi-mode microplate readers for life science applications and high-throughput screening. All microplate readers are manufactured and tested at BMG LABTECH’s headquarters in Germany, which guarantees their precision, reliability, and robustness over decades. BMG LABTECH continuously works with all of the leading reagent companies to handle the increasingly challenging requirements of popular microplate assays.
BMG LABTECH is aware that the development of innovative solutions to better serve the scientific community extremely benefits from the interaction between industry and academia. Thus, CEO Thomas Räbiger did not hesitate to encourage the establishment of a collaboration with both world renowned academic institutions as well as leading industrial partners within the EU-funded MetaCell-TM consortium.
The company has more than 25 years of expertise in microplate reading technology. For the experimental research and development of the project, the company provides the CLARIOstar® multi-mode microplate reader equipped with Atmospheric Control Unit (ACU), which enables O2 and CO2 gas regulation.
BMG LABTECH offers a wide range of microplate readers and accessories for use in life science, drug discovery, and other research areas.